Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

Saved in:
Bibliographic Details
Title: Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.
Authors: Akahoshi Y; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY.; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Katsivelos N; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Louloudis IE; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Weber D; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, MN., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Etra AM; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Aguayo-Hiraldo P; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA., Chanswangphuwana C; Division of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Choe HK; Division of Hematology, Blood and Marrow Transplantation Program, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Hexner EO; Department of Medicine and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Kitko CL; Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN., Al Malki MM; City of Hope, Duarte, CA., Merli P; Department of Pediatric Hematology/Oncology and of Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy., Olson TS; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Qayed M; Department of Pediatrics, Emory University School of Medicine, Emory University, Atlanta, GA., Vasova I; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany., Wölfl M; Pediatric Blood and Marrow Transplantation Program, Children's Hospital, University Hospital of Würzburg, Würzburg, Germany., Baez J; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Eng G; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Gleich S; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Morales G; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Spyrou N; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Young R; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Diniz M; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Nakamura R; City of Hope, Duarte, CA., Levine JE; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY., Ferrara JLM; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Source: Blood immunology & cellular therapy [Blood Immunol Cell Ther] 2026 Jun; Vol. 2 (2). Date of Electronic Publication: 2026 Apr 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9919050937306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3050-5976 (Electronic) Linking ISSN: 30505976 NLM ISO Abbreviation: Blood Immunol Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:3050-5976
DOI:10.1016/j.bict.2026.100044